Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Zhujiang Hospital
Mayo Clinic
Indiana University
Aura Biosciences
German CLL Study Group
M.D. Anderson Cancer Center
University of Vermont Medical Center
Shanghai Chest Hospital
University of Vermont Medical Center
American University of Beirut Medical Center
Centro de Excelencia en Enfermedades de Cabeza y Cuello
Tongji Hospital
Affiliated Cancer Hospital & Institute of Guangzhou Medical University